Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TPEX/6461 stock hub

TPEX/6461 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/6461is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/6461

In the news

Latest news · TPEX/6461

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/En/a

P25 14.4P50 18P75 31.9

ROE-40.6

P25 -16.2P50 0.3P75 9.8

ROIC-10

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/6461 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

175

Groups with data

Currency

TWD

Showing 175 of 175 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees	90
Employees Change	8%
Employees Change Percent	9.76
Enterprise value	TWD 4B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Biotechnology
Isin	TW0006461007
Last refreshed	2026-05-10
Market cap	TWD 3B
Price	TWD 16.95
Price currency	TWD
Sector	Healthcare
Sic	2834
Symbol	tpex/6461
Website	https://www.intechbiopharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-12.86%
EV Earnings	-10.28x
EV/FCF	-9.45x
EV/Sales	37.18x
FCF yield	-13.99%
P/B ratio	2.75x
P/S ratio	28.12x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBITDA Margin	-255.31%
Gross margin	-103.18%
Gross Profit	TWD -110.9M
Net Income	TWD -389M
Net Income Growth Years	0%
Pretax Margin	-355.47%
ROA	-9.6
Roa5y	-8.14
ROCE	-17.29
ROE	-40.62
Roe5y	-31.76
ROIC	-10.04

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-7.73%
Cagr1y	-3.99%
Cagr3y	-20.46%
Cagr5y	-3.8%
EPS Growth Quarters	1
EPS Growth Years	4
Revenue Growth	170.31x
Revenue Growth Q	-56.74x
Revenue Growth Years	3x
Revenue Growth3 Y	65.67x
Revenue Growth5 Y	38.49x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.05
Assets	TWD 2.4B
Cash	TWD 214.3M
Current Assets	TWD 403.1M
Current Liabilities	TWD 243.3M
Debt	TWD 1.2B
Debt Equity	TWD 1.08
Debt FCF	TWD -2.81
Equity	TWD 1.1B
Interest Coverage	-10.87
Liabilities	TWD 1.2B
Long Term Assets	TWD 1.9B
Long Term Liabilities	TWD 1B
Net Cash	TWD -974.3M
Net Cash By Market Cap	TWD -32.22
Net Debt Equity	TWD 0.88
Tangible Book Value	TWD 1.1B
Tangible Book Value Per Share	TWD 6.14
WACC	4.54

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.66
Inventory Turnover	2.42
Net Working Capital	TWD 138.6M
Quick ratio	0.91
Working Capital	TWD 159.8M
Working Capital Turnover	TWD 1.17

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-10.48%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-55.28%
1Y total return	-3.99%
200-day SMA	18.53
3Y total return	-49.68%
50-day SMA	19.26
50-day SMA vs 200-day SMA	50over200
5Y total return	-17.62%
All Time High	126
All Time High Change	-86.55%
All Time High Date	2014-07-15
All Time Low	11.45
All Time Low Change	48.03%
All Time Low Date	2020-03-23
ATR	0.71
Beta	0.22
Beta1y	0.54
Beta2y	0.75
Ch YTD	-4.78
High	17.3
High52	26.25
High52 Date	2026-03-02
High52ch	-35.43%
Low	16.8
Low52	14.1
Low52 Date	2025-11-24
Low52ch	20.21%
Ma50ch	-11.98%
Price vs 200-day SMA	-8.54%
RSI	34.59
RSI Monthly	41.37
RSI Weekly	43.04
Sharpe ratio	0.16x
Sortino ratio	0.4
Total Return	-10.48%
Tr YTD	-4.78
Tr1m	-5.83%
Tr1w	-2.59%
Tr3m	-27.72%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD -364.5M
Operating margin	-339

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	100,132,904%
Net Borrowing	-24,192,000
Shares Insiders	1%
Shares Institutions	5.88%
Shares Out	178,405,000
Shares Qo Q	0.67%
Shares Yo Y	10.48%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD -438.8M
Average Volume	261,180.45x
Bv Per Share	6.17
CAPEX	TWD -61.9M
Ch10y	-57.4
Ch1m	-5.83
Ch1w	-2.59
Ch1y	-5.57
Ch3m	-27.72
Ch3y	-51.78
Ch5y	-21.53
Ch6m	5.94
Change	-0.88%
Change From Open	-2.02
Close	17.1
Days Gap	1.17
Depreciation Amortization	89,980,000
Dollar Volume	1,017,610.2
Earnings Date	2026-05-12
EBIT	TWD -364.5M
EBITDA	TWD -274.5M
EPS	TWD -2.57
F Score	5
FCF	TWD -423M
FCF EV Yield	-10.58x
FCF Per Share	TWD -2.37
Financing CF	377,281,000
Fiscal Year End	December
Founded	2,010
Income Tax	TWD 6.8M
Investing CF	-197,476,000
Is Primary Listing	1
Last Earnings Date	2025-11-11
Last Report Date	2025-12-31
Ma150	18.24
Ma150ch	-7.07%
Ma20	18.18
Ma20ch	-6.77%
Net CF	-181,849,000
Next Earnings Date	2026-05-12
Open	17.3
Position In Range	30
Ppne	1,403,467,000
Price Date	2026-05-08
Ptbv Ratio	2.76
Relative Volume	0.23x
Revenue	107,527,000x
SBC By Revenue	14.66x
Share Based Comp	15,761,000
Tax By Revenue	6.33x
Tr6m	5.94%
Volume	60,036
Z Score	0.46

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TPEX/6461 pay a dividend?

Capital-return profile for this ticker.

Performance

TPEX/6461 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/6461?

Insider, institutional, and short-interest positioning.

Institutional ownership

+5.9%

Share of float held by funds and institutions

Insider ownership

+1.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+10.5%

Negative means the company is buying back shares.

Technical

TPEX/6461 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

34.6

Neutral momentum band

Price vs 200-day MA

-8.5%

50/200-day relationship not available

Beta (5Y)

0.22

Less volatile than the market

Sharpe ratio

0.16

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/6461

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/6461 stock rating?

tpex/6461 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/6461 analysis?

The full report lives at /stocks/tpex/6461/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/6461?

The latest report frames tpex/6461 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/6461 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.